{"id":1398,"date":"2020-04-16T08:06:44","date_gmt":"2020-04-16T06:06:44","guid":{"rendered":"http:\/\/farmapol.pl\/fundusze-unijne\/"},"modified":"2020-10-02T08:47:41","modified_gmt":"2020-10-02T06:47:41","slug":"fundusze-unijne","status":"publish","type":"page","link":"https:\/\/farmapol.pl\/en\/fundusze-unijne\/","title":{"rendered":"European Union Funds"},"content":{"rendered":"\n<p><strong>Project\u00a0<\/strong><strong>\u201cResearch and development on new medicine Asmag B6 Forte\u201d No <\/strong><strong>RPWP.01.02.00-30-0012\/19 implemented under the Regional Operational Programme of the Wielkopolska Region 2014-2020. <\/strong><strong>Measure: <\/strong><strong>1.2. The strengthening of the innovative potential of the Wielkopolska Region enterprises.<\/strong><\/p>\n<p><strong>Beneficiary: <\/strong><strong>ZAK\u0141AD CHEMICZNO \u2013 FARMACEUTYCZNY \u201cFARMAPOL\u201d SP\u00d3\u0141KA Z OGRANICZON\u0104 ODPOWIEDZIALNO\u015aCI\u0104<\/strong><\/p>\n<p>The aim of the project is to conduct research and development works in favour of the creation of Asmag B6 Forte medicine containing magnesium citrate and vitamin B6.<\/p>\n<p>As part of the project, development of laboratory infrastructure is planned for the purpose of R+D works.<\/p>\n<p><strong>Total value of the project:\u00a0<\/strong>PLN 931 400,00<\/p>\n<p><strong>Contribution of the EU:<\/strong><strong>\u00a0<\/strong>PLN 620\u00a0000,00<\/p>\n<p>The project is being implemented in Pozna\u0144 (ul. \u015aw. Wojciech 29, 61-749 Pozna\u0144)<\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<p><strong>\u00a0<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"107\" src=\"http:\/\/farmapol.pl\/wp-content\/uploads\/2020\/04\/flaga-1024x107.jpg\" alt=\"\" class=\"wp-image-1188\" srcset=\"https:\/\/farmapol.pl\/wp-content\/uploads\/2020\/04\/flaga-1024x107.jpg 1024w, https:\/\/farmapol.pl\/wp-content\/uploads\/2020\/04\/flaga-300x31.jpg 300w, https:\/\/farmapol.pl\/wp-content\/uploads\/2020\/04\/flaga-768x80.jpg 768w, https:\/\/farmapol.pl\/wp-content\/uploads\/2020\/04\/flaga-1536x161.jpg 1536w, https:\/\/farmapol.pl\/wp-content\/uploads\/2020\/04\/flaga-2048x214.jpg 2048w, https:\/\/farmapol.pl\/wp-content\/uploads\/2020\/04\/flaga-160x17.jpg 160w, https:\/\/farmapol.pl\/wp-content\/uploads\/2020\/04\/flaga-460x48.jpg 460w, https:\/\/farmapol.pl\/wp-content\/uploads\/2020\/04\/flaga-57x6.jpg 57w, https:\/\/farmapol.pl\/wp-content\/uploads\/2020\/04\/flaga-68x7.jpg 68w, https:\/\/farmapol.pl\/wp-content\/uploads\/2020\/04\/flaga-900x94.jpg 900w, https:\/\/farmapol.pl\/wp-content\/uploads\/2020\/04\/flaga-220x23.jpg 220w, https:\/\/farmapol.pl\/wp-content\/uploads\/2020\/04\/flaga-190x20.jpg 190w, https:\/\/farmapol.pl\/wp-content\/uploads\/2020\/04\/flaga-320x34.jpg 320w, https:\/\/farmapol.pl\/wp-content\/uploads\/2020\/04\/flaga-165x17.jpg 165w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Project\u00a0\u201cResearch and development on new medicine Asmag B6 Forte\u201d No RPWP.01.02.00-30-0012\/19 implemented under the Regional Operational Programme of the Wielkopolska Region 2014-2020. Measure: 1.2. The strengthening of the innovative potential of the Wielkopolska Region enterprises. Beneficiary: ZAK\u0141AD CHEMICZNO \u2013 FARMACEUTYCZNY \u201cFARMAPOL\u201d SP\u00d3\u0141KA Z OGRANICZON\u0104 ODPOWIEDZIALNO\u015aCI\u0104 The aim of the project is to conduct research and development works in favour of the creation of Asmag B6 Forte medicine containing magnesium citrate and vitamin B6. As part of the project, development of laboratory infrastructure is planned for the purpose of R+D works. Total value of the project:\u00a0PLN 931 400,00 Contribution of the EU:\u00a0PLN 620\u00a0000,00 The project is being implemented in Pozna\u0144 (ul. \u015aw. Wojciech 29, 61-749 Pozna\u0144) \u00a0 \u00a0<\/p>\n","protected":false},"author":5,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"class_list":["post-1398","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>European Union Funds - FARMAPOL Sp. z o.o.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/farmapol.pl\/en\/fundusze-unijne\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"European Union Funds - FARMAPOL Sp. z o.o.\" \/>\n<meta property=\"og:description\" content=\"Project\u00a0\u201cResearch and development on new medicine Asmag B6 Forte\u201d No RPWP.01.02.00-30-0012\/19 implemented under the Regional Operational Programme of the Wielkopolska Region 2014-2020. Measure: 1.2. The strengthening of the innovative potential of the Wielkopolska Region enterprises. Beneficiary: ZAK\u0141AD CHEMICZNO \u2013 FARMACEUTYCZNY \u201cFARMAPOL\u201d SP\u00d3\u0141KA Z OGRANICZON\u0104 ODPOWIEDZIALNO\u015aCI\u0104 The aim of the project is to conduct research and development works in favour of the creation of Asmag B6 Forte medicine containing magnesium citrate and vitamin B6. As part of the project, development of laboratory infrastructure is planned for the purpose of R+D works. Total value of the project:\u00a0PLN 931 400,00 Contribution of the EU:\u00a0PLN 620\u00a0000,00 The project is being implemented in Pozna\u0144 (ul. \u015aw. Wojciech 29, 61-749 Pozna\u0144) \u00a0 \u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/farmapol.pl\/en\/fundusze-unijne\/\" \/>\n<meta property=\"og:site_name\" content=\"FARMAPOL Sp. z o.o.\" \/>\n<meta property=\"article:modified_time\" content=\"2020-10-02T06:47:41+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/farmapol.pl\/wp-content\/uploads\/2020\/04\/flaga-1024x107.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/farmapol.pl\\\/en\\\/fundusze-unijne\\\/\",\"url\":\"https:\\\/\\\/farmapol.pl\\\/en\\\/fundusze-unijne\\\/\",\"name\":\"European Union Funds - FARMAPOL Sp. z o.o.\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmapol.pl\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/farmapol.pl\\\/en\\\/fundusze-unijne\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/farmapol.pl\\\/en\\\/fundusze-unijne\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/farmapol.pl\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/flaga-1024x107.jpg\",\"datePublished\":\"2020-04-16T06:06:44+00:00\",\"dateModified\":\"2020-10-02T06:47:41+00:00\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/farmapol.pl\\\/en\\\/fundusze-unijne\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/farmapol.pl\\\/en\\\/fundusze-unijne\\\/#primaryimage\",\"url\":\"http:\\\/\\\/farmapol.pl\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/flaga-1024x107.jpg\",\"contentUrl\":\"http:\\\/\\\/farmapol.pl\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/flaga-1024x107.jpg\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/farmapol.pl\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/farmapol.pl\\\/en\\\/\",\"name\":\"FARMAPOL Sp. z o.o.\",\"description\":\"leki, suplementy diety, kosmetyki\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/farmapol.pl\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"European Union Funds - FARMAPOL Sp. z o.o.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/farmapol.pl\/en\/fundusze-unijne\/","og_locale":"en_US","og_type":"article","og_title":"European Union Funds - FARMAPOL Sp. z o.o.","og_description":"Project\u00a0\u201cResearch and development on new medicine Asmag B6 Forte\u201d No RPWP.01.02.00-30-0012\/19 implemented under the Regional Operational Programme of the Wielkopolska Region 2014-2020. Measure: 1.2. The strengthening of the innovative potential of the Wielkopolska Region enterprises. Beneficiary: ZAK\u0141AD CHEMICZNO \u2013 FARMACEUTYCZNY \u201cFARMAPOL\u201d SP\u00d3\u0141KA Z OGRANICZON\u0104 ODPOWIEDZIALNO\u015aCI\u0104 The aim of the project is to conduct research and development works in favour of the creation of Asmag B6 Forte medicine containing magnesium citrate and vitamin B6. As part of the project, development of laboratory infrastructure is planned for the purpose of R+D works. Total value of the project:\u00a0PLN 931 400,00 Contribution of the EU:\u00a0PLN 620\u00a0000,00 The project is being implemented in Pozna\u0144 (ul. \u015aw. Wojciech 29, 61-749 Pozna\u0144) \u00a0 \u00a0","og_url":"https:\/\/farmapol.pl\/en\/fundusze-unijne\/","og_site_name":"FARMAPOL Sp. z o.o.","article_modified_time":"2020-10-02T06:47:41+00:00","og_image":[{"url":"http:\/\/farmapol.pl\/wp-content\/uploads\/2020\/04\/flaga-1024x107.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/farmapol.pl\/en\/fundusze-unijne\/","url":"https:\/\/farmapol.pl\/en\/fundusze-unijne\/","name":"European Union Funds - FARMAPOL Sp. z o.o.","isPartOf":{"@id":"https:\/\/farmapol.pl\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/farmapol.pl\/en\/fundusze-unijne\/#primaryimage"},"image":{"@id":"https:\/\/farmapol.pl\/en\/fundusze-unijne\/#primaryimage"},"thumbnailUrl":"http:\/\/farmapol.pl\/wp-content\/uploads\/2020\/04\/flaga-1024x107.jpg","datePublished":"2020-04-16T06:06:44+00:00","dateModified":"2020-10-02T06:47:41+00:00","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/farmapol.pl\/en\/fundusze-unijne\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/farmapol.pl\/en\/fundusze-unijne\/#primaryimage","url":"http:\/\/farmapol.pl\/wp-content\/uploads\/2020\/04\/flaga-1024x107.jpg","contentUrl":"http:\/\/farmapol.pl\/wp-content\/uploads\/2020\/04\/flaga-1024x107.jpg"},{"@type":"WebSite","@id":"https:\/\/farmapol.pl\/en\/#website","url":"https:\/\/farmapol.pl\/en\/","name":"FARMAPOL Sp. z o.o.","description":"leki, suplementy diety, kosmetyki","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/farmapol.pl\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/farmapol.pl\/en\/wp-json\/wp\/v2\/pages\/1398","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/farmapol.pl\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/farmapol.pl\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/farmapol.pl\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/farmapol.pl\/en\/wp-json\/wp\/v2\/comments?post=1398"}],"version-history":[{"count":3,"href":"https:\/\/farmapol.pl\/en\/wp-json\/wp\/v2\/pages\/1398\/revisions"}],"predecessor-version":[{"id":1507,"href":"https:\/\/farmapol.pl\/en\/wp-json\/wp\/v2\/pages\/1398\/revisions\/1507"}],"wp:attachment":[{"href":"https:\/\/farmapol.pl\/en\/wp-json\/wp\/v2\/media?parent=1398"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}